The Efficacy of Iron and Piracetam in Breath Holding Spells and Levetiracetam in Anoxic Epileptic Seizures

dc.contributor.author ÖZGÜN, Nezir
dc.contributor.author AKDENİZ, Osman
dc.contributor.author ÇELİK, Muhittin
dc.contributor.author SARBAY, Hakan
dc.contributor.author TOKTAŞ, İzzettin
dc.contributor.other Department of Internal Medical Sciences / Dahili Tıp Bilimleri Bölümü
dc.contributor.other 10. Faculty of Medicine / Tıp Fakültesi
dc.contributor.other 01. Mardin Artuklu University / Mardin Artuklu Üniversitesi
dc.date.accessioned 2023-12-25T12:00:14Z
dc.date.available 2023-12-25T12:00:14Z
dc.date.issued 2023
dc.description.abstract Introduction: In this study, the patients diagnosed with breath holding spell (BHS) or anoxic epileptic seizures and initiated at least one out of iron or piracetam or levetiracetam therapies were evaluated. Material and Methods: We retrospectively evaluated 194 BHS patients. Iron therapy was initiated in case of iron deficiency anemia or case of ferritin values under 12 ng/dl even if there was no anemia. The patients having no iron deficiency anemia, low ferritin and anoxic epileptic seizures were administered piracetam and the patients diagnosed with anoxic epileptic seizures were administered levetiracetam. Results: One hundred and eight patients (55.7%) were male. The mean age was 21.39±12.78 months. Iron therapy was initiated in 87 patients, piracetam to 96, and levetiracetam in 11 patients. Seizure numbers were manifestly decreased in all groups by the end of the first month after treatment concerning pretreatment levels (p<0.05). Conclusions: We determined that the spells were reduced or completely stopped in all groups. Levetiracetam seems to be considerably effective in patients developing anoxic epileptic seizures after BHS. en_US
dc.identifier.citation ÖZGÜN N, AKDENİZ O, ÇELİK M, SARBAY H, TOKTAŞ İ. The Efficacy of Iron and Piracetam in Breath Holding Spells and Levetiracetam in Anoxic Epileptic Seizures. Artuklu International Journal of Health Sciences. 2023;3(1):18-23. en_US
dc.identifier.doi 10.58252/artukluder.1227442
dc.identifier.uri https://dergipark.org.tr/en/pub/artukluder/issue/76730/1227442
dc.identifier.uri https://hdl.handle.net/20.500.12514/5185
dc.language.iso en en_US
dc.publisher Artuklu International Journal of Health Sciences en_US
dc.relation.ispartof Artuklu International Journal of Health Sciences en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Breath holding spell, Anoxic epileptic seizure, Treatment en_US
dc.title The Efficacy of Iron and Piracetam in Breath Holding Spells and Levetiracetam in Anoxic Epileptic Seizures en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.id 0000-0002-3616-9399
gdc.author.institutional Özgün, Nezir
gdc.author.institutional Özgün, Nezir
gdc.author.scopusid 57189501874
gdc.author.wosid GQB-0856-2022
gdc.coar.access open access
gdc.coar.type text::journal::journal article
gdc.description.department MAÜ, Fakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Halk Sağlığı Ana Bilim Dalı en_US
gdc.description.endpage 23 en_US
gdc.description.issue 1 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.startpage 18 en_US
gdc.description.volume 3 en_US
gdc.openalex.fwci 0.0
relation.isAuthorOfPublication 8b8b8e91-d38e-4df5-8f56-896753dcc270
relation.isAuthorOfPublication.latestForDiscovery 8b8b8e91-d38e-4df5-8f56-896753dcc270
relation.isOrgUnitOfPublication 8e5859b2-b0cf-4e18-9816-a07bcf1aa7ca
relation.isOrgUnitOfPublication 3f27f943-1869-4252-af6a-9ec8b114c727
relation.isOrgUnitOfPublication 39ccb12e-5b2b-4b51-b989-14849cf90cae
relation.isOrgUnitOfPublication.latestForDiscovery 8e5859b2-b0cf-4e18-9816-a07bcf1aa7ca

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
10.58252-artukluder.1227442-2864839.pdf
Size:
297.22 KB
Format:
Adobe Portable Document Format
Description:
Makale Dosyası

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.44 KB
Format:
Item-specific license agreed upon to submission
Description: